Pathogenesis and treatment of recurrent vulvovaginal candidiasis.
about
Cytokines in the host response to Candida vaginitis: Identifying a role for non-classical immune mediators, S100 alarminsDressed to impress: impact of environmental adaptation on the Candida albicans cell wallCandida albicans possesses Sap7 as a pepstatin A-insensitive secreted aspartic proteaseIn vivo activity of terpinen-4-ol, the main bioactive component of Melaleuca alternifolia Cheel (tea tree) oil against azole-susceptible and -resistant human pathogenic Candida speciesResistance of T-cell receptor delta-chain-deficient mice to experimental Candida albicans vaginitis.Expression of Candida glabrata adhesins after exposure to chemical preservatives.A vaccine and monoclonal antibodies that enhance mouse resistance to Candida albicans vaginal infection.Protocol for a randomised controlled trial of treatment of asymptomatic candidiasis for the prevention of preterm birth [ACTRN12610000607077].Infectious vaginitis. An accurate diagnosis is essential and attainable.Annexin-A1 identified as the oral epithelial cell anti-Candida effector moiety.Analysis of vaginal cell populations during experimental vaginal candidiasis.Effects of reproductive hormones on experimental vaginal candidiasis.Improvement of vaginal health for Kenyan women at risk for acquisition of human immunodeficiency virus type 1: results of a randomized trial.Local anticandidal immune responses in a rat model of vaginal infection by and protection against Candida albicansCell adhesion molecule and lymphocyte activation marker expression during experimental vaginal candidiasis.Recurrent vaginal candidiasis changes in etiopathogenical patterns.Vaginal epithelial cell anti-Candida albicans activity is associated with protection against symptomatic vaginal candidiasis.Intravaginal and intranasal immunizations are equally effective in inducing vaginal antibodies and conferring protection against vaginal candidiasisImmune cell-mediated protection against vaginal candidiasis: evidence for a major role of vaginal CD4(+) T cells and possible participation of other local lymphocyte effectors.Candida-specific antibodies during experimental vaginal candidiasis in mice.Immunity to Candida.Vaginal and oral epithelial cell anti-Candida activityRas pathway signaling accelerates programmed cell death in the pathogenic fungus Candida albicansEpithelial cell-derived S100 calcium-binding proteins as key mediators in the hallmark acute neutrophil response during Candida vaginitis.Oral and vaginal epithelial cell anti-Candida activity is acid labile and does not require live epithelial cells.Role for dendritic cells in immunoregulation during experimental vaginal candidiasisProspects for development of a vaccine to prevent and control vaginal candidiasis.Phenotypic and functional characterization of vaginal dendritic cells in a rat model of Candida albicans vaginitis.Candida albicans forms biofilms on the vaginal mucosa.Evaluation and management of vaginitisIncreased susceptibility of secretor factor gene Fut2-null mice to experimental vaginal candidiasisMucosal immunity and Candida albicans infection.Highly-cited estimates of the cumulative incidence and recurrence of vulvovaginal candidiasis are inadequately documented.Epithelial cell innate response to Candida albicansCandida albicans secreted aspartyl proteinases in virulence and pathogenesisFilament condition-specific response elements control the expression of NRG1 and UME6, key transcriptional regulators of morphology and virulence in Candida albicansImportance of Candida-bacterial polymicrobial biofilms in disease.What to do with the patient with recurrent vulvovaginal candidiasis.Vaginal yeast colonisation, prevalence of vaginitis, and associated local immunity in adolescents.Phenotypic Detection of Genitourinary Candidiasis among Sexually Transmitted Disease Clinic Attendees in Ladoke Akintola University Teaching Hospital, Osogbo, Nigeria
P2860
Q27021956-68CA8DB2-5393-4F01-9D47-B342AA69E538Q28085214-A7BF0731-1687-44A3-B67C-3CCFBA0F6255Q28481265-7FF08EBE-9B7F-4551-BC88-C5B7EA80A6AAQ33262661-97105F6A-9044-49A3-9B28-490615FC3D61Q33554217-A23E0393-5FA3-44A4-AA14-5B02A046845BQ33603262-964290D5-FC60-4E4F-B744-9DE4A0A7AB94Q33768705-9F4E75CC-4006-4774-BF0F-32ADEAD58BC8Q33843884-B0FC5A7D-6352-41A4-80FC-C193805B0B74Q33897706-41942B01-4B4C-49D9-9423-9968B5F766E0Q33997475-E46FD20E-94DF-4011-A580-CC7AE5256611Q34001275-0A7A6D3D-349D-497B-9FDB-EE009FC00BE7Q34003240-A4B85032-4A9F-4B96-921E-66964CA131D5Q34004099-47A900BA-AA81-41DD-ABF3-C272CB190AE8Q34004652-58A959D8-190F-479A-912C-4766202781F6Q34008683-ECDD4E8F-B884-425F-AB0B-FC28E67B6D56Q34105397-757E7637-DE8C-4601-A4E2-3781E8B95659Q34111909-622B9CE5-A7B9-47BE-9244-530DC9D18E7CQ34121150-1505115D-49BB-4E56-84EC-8FE17E5259EFQ34130381-7E1B0D2C-0525-477C-A1D3-525F4E702501Q34131799-924F74C3-D0A4-4CA8-8716-6B01513A97C6Q34143094-3A691C81-2700-4DAA-9672-D342422CACACQ34261507-C32152B9-24E4-431B-9EF0-54FEE45C9073Q34270785-073EE0BB-75CD-4C2D-B4E5-4139B564DA08Q34309699-E8357E3C-95BC-46C1-9756-4F5312336AB2Q34338040-F3DCFBED-C260-4111-AAA1-DA8F189D9ED9Q34681008-D1CA5A54-F3EC-4163-BBEF-909218ADE7D5Q34707478-ECD18CA4-BCD7-474C-9BA7-9946DCF9496BQ34720954-117A393A-9844-4C34-9AAC-13C79A182A2BQ34747087-DE0CD3F2-4E33-425B-9AC6-717638FFB990Q34751919-C911A7EB-78CA-417C-8F7D-8D0DDFCECF20Q34761565-9C9F3CFF-274D-4A7B-AB79-B158BAEAEFD8Q35109998-6BDDA832-A86A-4DF2-A9E1-E0AACA9CC7B3Q35115653-7A2A5B07-4966-45B2-B6D7-12269E037CC4Q35129083-BC870BE1-9D75-4712-B995-85EC8FA24C16Q35215948-75408DB1-6C15-4968-A88E-159929A67F07Q35220216-B5211036-FEDF-41B6-B45F-E43AF5B333C9Q35490098-3E160121-B328-4667-BD88-F4A1D97A4F62Q35562545-073B1BE1-8020-4CCD-AD2B-675C7F9D2703Q35562992-20FFE0C3-34AA-4731-A24F-3E7A6E76E733Q35625873-44EC7757-6C5E-46A6-A481-08E96EB3B91D
P2860
Pathogenesis and treatment of recurrent vulvovaginal candidiasis.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Pathogenesis and treatment of recurrent vulvovaginal candidiasis.
@ast
Pathogenesis and treatment of recurrent vulvovaginal candidiasis.
@en
type
label
Pathogenesis and treatment of recurrent vulvovaginal candidiasis.
@ast
Pathogenesis and treatment of recurrent vulvovaginal candidiasis.
@en
prefLabel
Pathogenesis and treatment of recurrent vulvovaginal candidiasis.
@ast
Pathogenesis and treatment of recurrent vulvovaginal candidiasis.
@en
P1476
Pathogenesis and treatment of recurrent vulvovaginal candidiasis.
@en
P2093
P304
P356
10.1093/CLINIDS/14.SUPPLEMENT_1.S148
P407
P478
14 Suppl 1
P577
1992-03-01T00:00:00Z